Cancer-focused Summer Undergraduate Research (CanSUR) Program
Cancer-focused Summer Undergraduate Research (CanSUR) Program
批准号:
10248314
负责人:
MARK W. JACKSON
金额:
$32.18万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2024-08-31
关键词:
3-DimensionalAcademiaAddressAdmission activityAdvocateBehavioralBiomedical ResearchCancer BiologyCareer ChoiceChargeClinicalCommittee MembersCommunicationCommunity OutreachComprehensive Cancer CenterCore FacilityDevelopmentEducationEducational CurriculumEducational workshopElevatorEnsureEnvironmentEvaluationFacultyFamilyFosteringFundingGoalsHabitsHealth ProfessionalHematologyImmersionIndividualIndustryJournalsLaboratoriesLearning ModuleLinkMalignant NeoplasmsMedicalMedicineMentorsMentorshipMinority GroupsOncologyOralOutcomePatientsPersonsPositioning AttributePostdoctoral FellowReportingReproducibilityResearchResearch PersonnelResearch TechnicsScientistSeriesSocial InteractionSolidStructureStudentsTrainingUnderrepresented MinorityUnderserved PopulationUniversitiesVocational GuidanceWarWritinganticancer researchcancer educationcancer therapycareercohortcollegecurriculum developmentdoctoral studentexperienceinnovationlecturesmedical schoolsmeetingsmembernovelpostersprogramsrecruitresponsible research conductsatisfactionskill acquisitionskillssummer programsymposiumundergraduate researchundergraduate research experienceundergraduate studentuniversity studentworkforce needs
中文摘要
项目摘要
癌症一直是生物医学研究的一个主要焦点,因为对癌症的战争开始与国家
1971年癌症法案。尽管如此,全世界每年仍有近800万人死于癌症。帮助
确保国家的生物医学,临床和行为癌症研究队伍保持强大,我们
建议开发以癌症为重点的夏季本科生研究计划(CanSUR),
招募来自不同背景的积极性很高的本科生,并培养他们对一个
从事癌症研究。CanSUR计划每年将支持32名本科学者,招募
来自地区和国家学院/大学的学生参加为期10周的癌症研究
与Case Comprehensive Cancer Center(Case CCC)成员一起工作的经验。关键目标
CanSUR计划的目的是:(1)为每位学者提供一个案例CCC的夏季癌症研究经验
成员实验室;(2)促进对生物医学,癌症研究职业机会的理解和(3)
为他们提供科学知识和专业技能课程,帮助他们为下一个阶段做好准备,
专注于癌症研究的职业。为实现这些目标,制定了四个主要组成部分,
包括密集的第一周癌症沉浸研讨会,一系列互动式癌症研究讲座
关于癌症生物学的基础知识,当前的癌症疗法,癌症研究技术,癌症职业生涯
路径和创新的三维癌症教育模块(称为HoloLens)。我们提出了一个新的2-
一种分层导师制结构,包括初级导师(实验室负责人)和初级导师,
负责在研究环境中对CanSUR学者进行日常培训的人员。
除了他们的个人研究经验,我们还开发了一系列科学浓缩组件
它解决了癌症研究中的重要问题,例如培养专业习惯,有效
沟通策略,以及对癌症如何影响个人及其家庭的认识(使用谈话
病人的拥护者)。将介绍许多以癌症为重点的职业道路,并指导如何
为下一步的具体职业道路做准备将由研究生和医学院招生提供
董事、已实现癌症相关职业目标的专业人员和目前的学员。鉴于
我们的目标的重要性,我们已经承诺显着的机构支持,并有82名教师和
专注于癌症教育的机构领导人准备招募和培养优秀的本科生,
这个暑期项目。因此,我们有能力将积极进取的本科生转化为
国家的下一个癌症研究团队。
英文摘要
PROJECT SUMMARY
Cancer has been a major focus of biomedical research since the war on cancer began with the National
Cancer Act of 1971. Despite this focus, nearly 8 million people die of cancer each year, worldwide. To help
ensure that the nations’ biomedical, clinical, and behavioral cancer research workforce remains strong, we
propose the development of a Cancer-focused Summer Undergraduate Research (CanSUR) Program, to
recruit highly motivated undergraduate students from diverse backgrounds and foster their excitement for a
career in cancer research. The CanSUR program will support 32 undergraduate scholars each year, recruited
from regional and national colleges/universities for a 10-week period, to participate in a cancer research
experience with members of the Case Comprehensive Cancer Center (Case CCC). Key objectives of the
CanSUR Program are to: (1) provide each scholar with a summer cancer research experience in a Case CCC
members lab; (2) foster an understanding of biomedical, cancer research career opportunities and (3)
providing scientific enrichment and professional skills curriculum to help prepare them for the next step in a
cancer research focused career. Four major components have been developed to meet these objectives,
including an Intensive Week 1 Cancer Immersion Workshop, a series of interactive cancer research lectures
on the fundamentals of cancer biology, current cancer therapies, cancer research techniques, cancer career
paths and innovative 3-dimensional cancer education modules (called the HoloLens). We propose a novel 2-
tier mentorship structure that includes both the primary mentor (lab leader), and a junior mentor, which will be
the person in charge of the day-to-day training of the CanSUR scholar within the research environment.
Beyond their individual research experience, we have developed a series of Scientific Enrichment components
which address important issues in cancer research, such as developing professional habits, effective
communication strategies, and an appreciation of how cancer impacts individuals and their families (using talks
by patient advocates). Numerous cancer-focused career paths will be introduced, and guidance about how to
prepare for the next step of a specific career path will be provided by graduate and medical school admissions
directors, professionals who have achieved their cancer-related career goals, and current trainees. Given the
importance of our objectives, we have been pledged significant institutional support and have 82 faculty and
institutional leaders who focus on cancer education prepared to recruit and train outstanding undergraduates in
this summer program. As such, we are well-positioned to convert highly-motivated undergraduates into the
nation’s next cancer research workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
-
批准号:10704231
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2022
-
负责人:MARK W. JACKSON
-
依托单位:
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
-
批准号:10493939
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2022
-
负责人:MARK W. JACKSON
-
依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
-
批准号:10364703
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2021
-
负责人:MARK W. JACKSON
-
依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
-
批准号:10576854
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2021
-
负责人:MARK W. JACKSON
-
依托单位:
Defining the role of FAM83B in lung cancer using a new mouse model
-
批准号:10201807
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2021
-
负责人:MARK W. JACKSON
-
依托单位:
Defining the role of FAM83B in lung cancer using a new mouse model
-
批准号:10373095
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2021
-
负责人:MARK W. JACKSON
-
依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
-
批准号:10211081
-
项目类别:
-
资助金额:$41.28万
-
财政年份:2021
-
负责人:MARK W. JACKSON
-
依托单位:
Cancer-focused Summer Undergraduate Research (CanSUR) Program
-
批准号:10469505
-
项目类别:
-
资助金额:$30.37万
-
财政年份:2018
-
负责人:MARK W. JACKSON
-
依托单位:
Cancer-focused Summer Undergraduate Research (CanSUR) Program
-
批准号:10678931
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2018
-
负责人:MARK W. JACKSON
-
依托单位:
Cancer-focused Summer Undergraduate Research (CanSUR) Program
-
批准号:9752503
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2018
-
负责人:MARK W. JACKSON
-
依托单位:
Interferon-beta inhibits the expansion of cancer stem-cells
-
批准号:9099008
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2016
-
负责人:MARK W. JACKSON
-
依托单位:
Defining the role of FAM83A in Herceptin-resistant breast cancer
-
批准号:9022860
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2015
-
负责人:MARK W. JACKSON
-
依托单位:
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor
-
批准号:8568176
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2013
-
负责人:MARK W. JACKSON
-
依托单位:
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
-
批准号:8566336
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2013
-
负责人:MARK W. JACKSON
-
依托单位:
A Strategy for Reactivating p53 in Cancer Stem Cells Using a Novel HdmX Inhibitor
-
批准号:8689986
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2013
-
负责人:MARK W. JACKSON
-
依托单位:
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
-
批准号:8693978
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2013
-
负责人:MARK W. JACKSON
-
依托单位:
Identification of a noval oncogene using validation-based insertional mutagenesis
-
批准号:8615914
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2010
-
负责人:MARK W. JACKSON
-
依托单位:
Identification of a noval oncogene using validation-based insertional mutagenesis
-
批准号:8215857
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2010
-
负责人:MARK W. JACKSON
-
依托单位:
Identification of a noval oncogene using validation-based insertional mutagenesis
-
批准号:7885130
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2010
-
负责人:MARK W. JACKSON
-
依托单位:
Identification of a noval oncogene using validation-based insertional mutagenesis
-
批准号:8069233
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2010
-
负责人:MARK W. JACKSON
-
依托单位:
海外基金